Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply
Standard
Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply. / Krause, Linda; Mueller, Nikola S; Eyerich, Stefanie.
in: J ALLERGY CLIN IMMUN, Jahrgang 139, Nr. 3, 03.2017, S. 1065-1066.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply
AU - Krause, Linda
AU - Mueller, Nikola S
AU - Eyerich, Stefanie
PY - 2017/3
Y1 - 2017/3
KW - Biomarkers
KW - Computational Biology
KW - Dermatitis, Atopic
KW - Eczema
KW - Humans
KW - Letter
KW - Research Support, Non-U.S. Gov't
KW - Comment
U2 - 10.1016/j.jaci.2016.08.024
DO - 10.1016/j.jaci.2016.08.024
M3 - SCORING: Journal article
C2 - 28341481
VL - 139
SP - 1065
EP - 1066
JO - J ALLERGY CLIN IMMUN
JF - J ALLERGY CLIN IMMUN
SN - 0091-6749
IS - 3
ER -